197 related articles for article (PubMed ID: 19113831)
41. Relative Quantification and Higher-Order Modeling of the Plasma Glycan Cancer Burden Ratio in Ovarian Cancer Case-Control Samples.
Hecht ES; Scholl EH; Walker SH; Taylor AD; Cliby WA; Motsinger-Reif AA; Muddiman DC
J Proteome Res; 2015 Oct; 14(10):4394-401. PubMed ID: 26347193
[TBL] [Abstract][Full Text] [Related]
42. Analysis of carbohydrates on proteins by offline normal-phase liquid chromatography MALDI-TOF/TOF-MS/MS.
Tryfona T; Stephens E
Methods Mol Biol; 2010; 658():137-51. PubMed ID: 20839102
[TBL] [Abstract][Full Text] [Related]
43. N-glycosylation of colorectal cancer tissues: a liquid chromatography and mass spectrometry-based investigation.
Balog CI; Stavenhagen K; Fung WL; Koeleman CA; McDonnell LA; Verhoeven A; Mesker WE; Tollenaar RA; Deelder AM; Wuhrer M
Mol Cell Proteomics; 2012 Sep; 11(9):571-85. PubMed ID: 22573871
[TBL] [Abstract][Full Text] [Related]
44. Detection of hepatocellular carcinoma using glycomic analysis.
Goldman R; Ressom HW; Varghese RS; Goldman L; Bascug G; Loffredo CA; Abdel-Hamid M; Gouda I; Ezzat S; Kyselova Z; Mechref Y; Novotny MV
Clin Cancer Res; 2009 Mar; 15(5):1808-13. PubMed ID: 19223512
[TBL] [Abstract][Full Text] [Related]
45. N-linked glycan structures and their expressions change in the blood sera of ovarian cancer patients.
Alley WR; Vasseur JA; Goetz JA; Svoboda M; Mann BF; Matei DE; Menning N; Hussein A; Mechref Y; Novotny MV
J Proteome Res; 2012 Apr; 11(4):2282-300. PubMed ID: 22304416
[TBL] [Abstract][Full Text] [Related]
46. Isomeric separation of native N-glycans using nano zwitterionic- hydrophilic interaction liquid chromatography column.
Daramola O; Gutierrez-Reyes CD; Wang J; Nwaiwu J; Onigbinde S; Fowowe M; Dominguez M; Mechref Y
J Chromatogr A; 2023 Aug; 1705():464198. PubMed ID: 37442073
[TBL] [Abstract][Full Text] [Related]
47. Targeted mass spectrometric approach for biomarker discovery and validation with nonglycosylated tryptic peptides from N-linked glycoproteins in human plasma.
Lee JY; Kim JY; Park GW; Cheon MH; Kwon KH; Ahn YH; Moon MH; Lee HJ; Paik YK; Yoo JS
Mol Cell Proteomics; 2011 Dec; 10(12):M111.009290. PubMed ID: 21940909
[TBL] [Abstract][Full Text] [Related]
48. Clinical Significance of Tissue Factor Pathway Inhibitor 2, a Serum Biomarker Candidate for Ovarian Clear Cell Carcinoma.
Arakawa N; Kobayashi H; Yonemoto N; Masuishi Y; Ino Y; Shigetomi H; Furukawa N; Ohtake N; Miyagi Y; Hirahara F; Hirano H; Miyagi E
PLoS One; 2016; 11(10):e0165609. PubMed ID: 27798689
[TBL] [Abstract][Full Text] [Related]
49. Blood Plasma-Derived Anti-Glycan Antibodies to Sialylated and Sulfated Glycans Identify Ovarian Cancer Patients.
Pochechueva T; Chinarev A; Schoetzau A; Fedier A; Bovin NV; Hacker NF; Jacob F; Heinzelmann-Schwarz V
PLoS One; 2016; 11(10):e0164230. PubMed ID: 27764122
[TBL] [Abstract][Full Text] [Related]
50. Comparison of hydrophilic-interaction, reversed-phase and porous graphitic carbon chromatography for glycan analysis.
Melmer M; Stangler T; Premstaller A; Lindner W
J Chromatogr A; 2011 Jan; 1218(1):118-23. PubMed ID: 21122866
[TBL] [Abstract][Full Text] [Related]
51. Serum leucine-rich alpha-2-glycoprotein-1 with fucosylated triantennary N-glycan: a novel colorectal cancer marker.
Shinozaki E; Tanabe K; Akiyoshi T; Tsuchida T; Miyazaki Y; Kojima N; Igarashi M; Ueno M; Suenaga M; Mizunuma N; Yamaguchi K; Nakayama K; Iijima S; Yamaguchi T
BMC Cancer; 2018 Apr; 18(1):406. PubMed ID: 29642865
[TBL] [Abstract][Full Text] [Related]
52. Evaluation of glycomic profiling as a diagnostic biomarker for epithelial ovarian cancer.
Kim K; Ruhaak LR; Nguyen UT; Taylor SL; Dimapasoc L; Williams C; Stroble C; Ozcan S; Miyamoto S; Lebrilla CB; Leiserowitz GS
Cancer Epidemiol Biomarkers Prev; 2014 Apr; 23(4):611-21. PubMed ID: 24557531
[TBL] [Abstract][Full Text] [Related]
53. Glycan reductive isotope labeling for quantitative glycomics.
Xia B; Feasley CL; Sachdev GP; Smith DF; Cummings RD
Anal Biochem; 2009 Apr; 387(2):162-70. PubMed ID: 19454239
[TBL] [Abstract][Full Text] [Related]
54. Structural and quantitative analysis of N-linked glycans by matrix-assisted laser desorption ionization and negative ion nanospray mass spectrometry.
Harvey DJ; Royle L; Radcliffe CM; Rudd PM; Dwek RA
Anal Biochem; 2008 May; 376(1):44-60. PubMed ID: 18294950
[TBL] [Abstract][Full Text] [Related]
55. Isomer-specific profiling of N-glycans derived from human serum for potential biomarker discovery in pancreatic cancer.
Liu Y; Wang C; Wang R; Wu Y; Zhang L; Liu BF; Cheng L; Liu X
J Proteomics; 2018 Jun; 181():160-169. PubMed ID: 29674015
[TBL] [Abstract][Full Text] [Related]
56. Haptoglobin-alpha subunit as potential serum biomarker in ovarian cancer: identification and characterization using proteomic profiling and mass spectrometry.
Ye B; Cramer DW; Skates SJ; Gygi SP; Pratomo V; Fu L; Horick NK; Licklider LJ; Schorge JO; Berkowitz RS; Mok SC
Clin Cancer Res; 2003 Aug; 9(8):2904-11. PubMed ID: 12912935
[TBL] [Abstract][Full Text] [Related]
57. NEGATIVE ION MASS SPECTROMETRY FOR THE ANALYSIS OF N-LINKED GLYCANS.
Harvey DJ
Mass Spectrom Rev; 2020 Sep; 39(5-6):586-679. PubMed ID: 32329121
[TBL] [Abstract][Full Text] [Related]
58. Identification of metabolic biomarkers to diagnose epithelial ovarian cancer using a UPLC/QTOF/MS platform.
Fan L; Zhang W; Yin M; Zhang T; Wu X; Zhang H; Sun M; Li Z; Hou Y; Zhou X; Lou G; Li K
Acta Oncol; 2012 Apr; 51(4):473-9. PubMed ID: 22283470
[TBL] [Abstract][Full Text] [Related]
59. LC-MS/MS isomeric profiling of permethylated N-glycans derived from serum haptoglobin of hepatocellular carcinoma (HCC) and cirrhotic patients.
Huang Y; Zhou S; Zhu J; Lubman DM; Mechref Y
Electrophoresis; 2017 Sep; 38(17):2160-2167. PubMed ID: 28543513
[TBL] [Abstract][Full Text] [Related]
60. Study on early diagnosis of epithelial ovarian cancer by analysis of plasma septin-9 and clusterin level.
Lyu N; Wang Y; Wang J; Zhang Z; Kong W
J Cancer Res Ther; 2018 Jun; 14(Supplement):S444-S449. PubMed ID: 29970704
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
